+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma



Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma



Proceedings of the National Academy of Sciences of the United States of America 111(39): 14217-14222



Somatic mutation of isocitrate dehydrogenase 1 (IDH1) is now recognized as the most common initiating event for secondary glioblastoma, a brain tumor type arising with high frequency in the frontal lobe. A puzzling feature of IDH1 mutation is the selective manifestation of glioma as the only neoplasm frequently associated with early postzygotic occurrence of this genomic alteration. We report here that IDH1(R132H) exhibits a growth-inhibitory effect that is abrogated in the presence of glutamate dehydrogenase 2 (GLUD2), a hominoid-specific enzyme purportedly optimized to facilitate glutamate turnover in human forebrain. Using murine glioma progenitor cells, we demonstrate that IDH1(R132H) exerts a growth-inhibitory effect that is paralleled by deficiency in metabolic flux from glucose and glutamine to lipids. Examining human gliomas, we find that glutamate dehydrogenase 1 (GLUD1) and GLUD2 are overexpressed in IDH1-mutant tumors and that orthotopic growth of an IDH1-mutant glioma line is inhibited by knockdown of GLUD1/2. Strikingly, introduction of GLUD2 into murine glioma progenitor cells reverses deleterious effects of IDH1 mutation on metabolic flux and tumor growth. Further, we report that glutamate, a substrate of GLUD2 and a neurotransmitter abundant in mammalian neocortex, can support growth of glioma progenitor cells irrespective of IDH1 mutation status. These findings suggest that specialization of human neocortex for high glutamate neurotransmitter flux creates a metabolic niche conducive to growth of IDH1 mutant tumors.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053575114

Download citation: RISBibTeXText

PMID: 25225364

DOI: 10.1073/pnas.1409653111


Related references

OS2.6Identification of IDH1R132H-specific T cell receptors from a humanized mouse model and from glioma patients treated with an IDH1R132H-specific peptide vaccine. Neuro-Oncology 18(Suppl_4): Iv5-Iv6, 2016

Os09.9 Identification of Idh1R132H-specific T cell receptors from glioma patients and from Mhc-humanized mice. Neuro-Oncology 19(Suppl_3): iii20, 2017

Csig-40. Heterozygous Idh1R132H/Wt Created By Single Base Editing Inhibits Human Astroglial Cell Growth And Promotes Cell Migration. Neuro-Oncology 20(Suppl_6): vi52, 2018

O4.08 * Agi5198, An Inhibitor Of Idh1R132H, Protects Idh1R132H Hct116 Cells Against Irradiation. Neuro-Oncology 16(Suppl 2): ii8-ii9, 2014

P09.04Adoptive T cell therapy for Idh1R132H-mutated low-grade glioma. Neuro-Oncology 18(Suppl_4): iv60, 2016

Spontaneous in vitro senescence of glioma cells confirmed by an antibody against IDH1R132H. Anticancer Research 34(6): 2859-2867, 2014

IDH1R¹³²H decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a. Molecular Medicine Reports 12(5): 6695-6701, 2015

Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21. Biochemical and Biophysical Research Communications 454(1): 221-227, 2014

TBC1D3, a hominoid-specific gene, delays IRS-1 degradation and promotes insulin signaling by modulating p70 S6 kinase activity. Plos one 7(2): E31225, 2012

Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion. Plos one 10(7): E0132399, 2015

A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochemical and Biophysical Research Communications 390(3): 547-551, 2009

The hominoid-specific gene TBC1D3 promotes generation of basal neural progenitors and induces cortical folding in mice. Elife 5:, 2016

IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway. Neoplasia 20(2): 207-217, 2018

Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression. Ebiomedicine 37: 56-67, 2018

P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway. International Journal of Biochemistry and Cell Biology 45(6): 1109-1120, 2013